75 results
8-K
EX-99.1
2o2 tnszog4ctup4
20 Sep 21
BioCryst Appoints Dr. Amy McKee to Board of Directors
7:06am
8-K
EX-99.1
e9t98e
22 Jan 21
BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema
7:12am
424B2
buuy xure
29 May 20
Prospectus for primary offering
6:07am
424B5
xruayivtu h2
27 May 20
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
xukiht 051lrt
30 Mar 20
Other Events
7:20am
8-K
EX-99.1
2u24bpik ztb5kn
25 Feb 20
BioCryst Appoints Alan G. Levin to Board of Directors
7:05am
8-K
EX-99.1
9rr4k
5 Nov 19
BioCryst Announces Partnership With Torii Pharmaceutical to Commercialize BCX7353 in Japan for the Prevention of HAE Attacks
7:02am